Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.14

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.14). Revenue for the quarter came in at $10.44 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• EQT And KKKR Said Among Firms Considering Bids For Qiagen - Bloomberg
• Truist on agilon health Inc (AGL): 'From Stabilization to Value Creation'
• Trump Sets Jan. 1, 2027 For 50% Canada Tariff Hike